These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8626006)

  • 1. The transmission dynamics of hepatitis B in the UK: a mathematical model for evaluating costs and effectiveness of immunization programmes.
    Williams JR; Nokes DJ; Medley GF; Anderson RM
    Epidemiol Infect; 1996 Feb; 116(1):71-89. PubMed ID: 8626006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted hepatitis B vaccination--a cost effective immunisation strategy for the UK?
    Williams JR; Nokes DJ; Anderson RM
    J Epidemiol Community Health; 1996 Dec; 50(6):667-73. PubMed ID: 9039387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus infection in patients attending a genitourinary medicine clinic: risk factors and vaccine coverage.
    Gilson RJ; de Ruiter A; Waite J; Ross E; Loveday C; Howell DR; Tedder RS; Weller IV
    Sex Transm Infect; 1998 Apr; 74(2):110-5. PubMed ID: 9634322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
    Zhao S; Xu Z; Lu Y
    Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
    Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
    Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a change in the epidemiology of hepatitis B virus infection after nearly two decades of universal hepatitis B vaccination in South Africa.
    Amponsah-Dacosta E; Lebelo RL; Rakgole JN; Burnett RJ; Selabe SG; Mphahlele MJ
    J Med Virol; 2014 Jun; 86(6):918-24. PubMed ID: 24615635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
    Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
    Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of hepatitis B infection: the appropriate strategy for India.
    Aggarwal R; Naik SR
    Natl Med J India; 1994; 7(5):216-20. PubMed ID: 7827601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination against hepatitis B in low endemic countries.
    Kretzschmar M; de Wit GA; Smits LJ; van de Laar MJ
    Epidemiol Infect; 2002 Apr; 128(2):229-44. PubMed ID: 12002541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
    Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
    Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
    Krahn M; Detsky AS
    Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An update after 16 years of hepatitis B vaccination in South Africa.
    Burnett RJ; Kramvis A; Dochez C; Meheus A
    Vaccine; 2012 Sep; 30 Suppl 3():C45-51. PubMed ID: 22939021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
    Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
    JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
    Scott N; Palmer A; Morgan C; Lesi O; Spearman CW; Sonderup M; Hellard M
    Lancet Glob Health; 2018 Jun; 6(6):e659-e667. PubMed ID: 29773122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A molecular epidemiological study of the hepatitis B virus in Thailand after 22 years of universal immunization.
    Yimnoi P; Posuwan N; Wanlapakorn N; Tangkijvanich P; Theamboonlers A; Vongpunsawad S; Poovorawan Y
    J Med Virol; 2016 Apr; 88(4):664-73. PubMed ID: 26331587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
    Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
    J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vertical HBV transmission in Jerusalem in the vaccine era].
    Michaiel R; Margalit RC; Shteyer E; Ashur Y; Safadi R
    Harefuah; 2012 Dec; 151(12):671-4, 722, 721. PubMed ID: 23330257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.